The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Characterization of a Novel Subtype of Human G Protein-coupled Receptor for Lysophosphatidic Acid
Open accessAbstract
The recent identification of the Vzg-1/Edg2 protein as a functional G protein-coupled receptor for lysophosphatidic acid (LPA) has allowed a sequence-based search for new genes that may encode novel subtypes of LPA receptors. A human cDNA encoding a G protein-coupled receptor, designated Edg4, was identified by searching the GenBankTM for homologs of the human Edg2 LPA receptor. The Edg4 protein is 46% identical and 72% similar in amino acid sequence to human Edg2. When overexpressed in Jurkat T cells, the Edg4 protein mediated LPA-induced activation of a serum response element reporter gene with LPA concentration dependence (EC50 of 10 nM) and specificity. This LPA-induced reporter gene activation could be partially inhibited by pretreatment with pertussis toxin or C3 exoenzyme, suggesting requirements for both a Gi protein and Rho GTPase. Overexpression of Edg4 in Jurkat cells also led to increases in specific binding sites for [3H]LPA. Northern blots revealed that two edg4 mRNA transcripts of 1.8 and 8 kilobases are distributed very differently from edg2 mRNAs in adult human tissues and several cancer cell lines. The existence and distinctive tissue expression of structurally different subtypes of LPA receptors may provide one basis for tissue-specific functions and permit independent regulation of each subtype of LPA receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Ridley, A. J., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90163-7 · Cited by 4,468
The Rho family GTPases RhoA, Racl , and CDC42Hsregulate transcriptional activation by SRF
Hill, C. S., Wynne, J., & Treisman, R. (1995) · Cell · doi:10.1016/s0092-8674(05)80020-0 · Cited by 1,269
Hecht, J. H., Weiner, J. A., Post, S. R., & Chun, J. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.4.1071 · Cited by 720
The bioactive phospholipid lysophosphatidic acid is released from activated platelets
Eichholtz, T., Jalink, K., Fahrenfort, I., & Moolenaar, W. H. (1993) · Biochemical Journal · doi:10.1042/bj2910677 · Cited by 645
Lysophosphatidic Acid, a Multifunctional Phospholipid Messenger
Moolenaar, W. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12949 · Cited by 584
Lysophosphatidic acid: G-protein signalling and cellular responses
Moolenaar, W. H., Kranenburg, O., Postma, F. R., & Zondag, G. C. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80059-2 · Cited by 486
Hla, T., & Maciag, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38849-0 · Cited by 476
Tigyi, G., & Miledi, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36618-9 · Cited by 346
Cited by
The emerging role of lysophosphatidic acid in cancer
Mills, G. B., & Moolenaar, W. H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1143 · Cited by 1,094
Lee, M.-J., Thangada, S., Claffey, K. P., Ancellin, N., Liu, C. H., Kluk, M., Volpi, M., Sha'afi, R. I., & Hla, T. (1999) · Cell · doi:10.1016/s0092-8674(00)81661-x · Cited by 1,013
Umezu-Goto, M., Kishi, Y., Taira, A., Hama, K., Dohmae, N., Takio, K., Yamori, T., Mills, G. B., Inoue, K., Aoki, J., et al. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200204026 · Cited by 929
LPA Receptors: Subtypes and Biological Actions
Choi, J. W., Herr, D. R., Noguchi, K., Yung, Y. C., Lee, C.-W., Mutoh, T., Lin, M.-E., Teo, S. T., Park, K. E., Mosley, A. N., et al. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105753 · Cited by 839
Lysophospholipid Receptors: Signaling and Biology
Ishii, I., Fukushima, N., Ye, X., & Chun, J. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073731 · Cited by 771
Sphingosine 1-phosphate signalling in mammalian cells
Pyne, S., & Pyne, N. J. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490385 · Cited by 735
LPA receptor signaling: pharmacology, physiology, and pathophysiology
Yung, Y. C., Stoddard, N. C., & Chun, J. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046458 · Cited by 710
Noguchi, K., Ishii, S., & Shimizu, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302648200 · Cited by 557
Lysophospholipids--Receptor Revelations
Hla, T., Lee, M.-J., Ancellin, N., Paik, J. H., & Kluk, M. J. (2001) · Science · doi:10.1126/science.1065323 · Cited by 537
Goetzl, E. J., & An, S. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.15.1589 · Cited by 512
Self-citationBandoh, K., Aoki, J., Hosono, H., Kobayashi, S., Kobayashi, T., Murakami-Murofushi, K., Tsujimoto, M., Arai, H., & Inoue, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27776 · Cited by 511
Requirement for the lp A1 lysophosphatidic acid receptor gene in normal suckling behavior
Contos, J. J. A., Fukushima, N., Weiner, J. A., Kaushal, D., & Chun, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.24.13384 · Cited by 479
GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5
Lee, C.-W., Rivera, R., Gardell, S., Dubin, A. E., & Chun, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603670200 · Cited by 471
International Union of Pharmacology. XXXIV. Lysophospholipid Receptor Nomenclature
Chun, J., Goetzl, E. J., Hla, T., Igarashi, Y., Lynch, K. R., Moolenaar, W., Pyne, S., & Tigyi, G. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.265 · Cited by 464
Self-citationBoucharaba, A., Serre, C.-M., Grès, S., Saulnier-Blache, J. S., Bordet, J.-C., Guglielmi, J., Clézardin, P., & Peyruchaud, O. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422123 · Cited by 462
Two pathways for lysophosphatidic acid production
AOKI, J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2008.06.005 · Cited by 448
Serum Lysophosphatidic Acid Is Produced through Diverse Phospholipase Pathways
Aoki, J., Taira, A., Takanezawa, Y., Kishi, Y., Hama, K., Kishimoto, T., Mizuno, K., Saku, K., Taguchi, R., & Arai, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206812200 · Cited by 429
Bioactive Lysophospholipids and Their G Protein-Coupled Receptors
Moolenaar, W. H. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4702 · Cited by 407
Lysophosphatidic Acid Receptors
Contos, J. J. A., Ishii, I., & Chun, J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12687-9 · Cited by 404
Siess, W., Zangl, K. J., Essler, M., Bauer, M., Brandl, R., Corrinth, C., Bittman, R., Tigyi, G., & Aepfelbacher, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6931 · Cited by 404
Ki16425, a Subtype-Selective Antagonist for EDG-Family Lysophosphatidic Acid Receptors
Ohta, H., Sato, K., Murata, N., Damirin, A., Malchinkhuu, E., Kon, J., Kimura, T., Tobo, M., Yamazaki, Y., Watanabe, T., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.4.994 · Cited by 402
Sphingosine 1-Phosphate Stimulates Cell Migration through a Gi-coupled Cell Surface Receptor
Wang, F., Van Brocklyn, J. R., Hobson, J. P., Movafagh, S., Zukowska-Grojec, Z., Milstien, S., & Spiegel, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35343 · Cited by 368
Target validation of G-protein coupled receptors
Wise, A., Gearing, K., & Rees, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02131-6 · Cited by 359
Role of vascular endothelial growth factor in ovarian physiology and pathology
Geva, E., & Jaffe, R. B. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(00)00670-1 · Cited by 356
Windh, R. T., Lee, M.-J., Hla, T., An, S., Barr, A. J., & Manning, D. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.39.27351 · Cited by 333
Self-citationChun, J., Hla, T., Lynch, K. R., Spiegel, S., & Moolenaar, W. H. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003111 · Cited by 330
Lysophospholipid receptor nomenclature review: IUPHAR Review 8
Kihara, Y., Maceyka, M., Spiegel, S., & Chun, J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12678 · Cited by 324
Fukushima, N., Ishii, I., Contos, J. J., Weiner, J. A., & Chun, J. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.507 · Cited by 322
Contos, J. J. A., Ishii, I., Fukushima, N., Kingsbury, M. A., Ye, X., Kawamura, S., Brown, J. H., & Chun, J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.19.6921-6929.2002 · Cited by 316
Groves, A., Kihara, Y., & Chun, J. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.02.011 · Cited by 314
Ammit, A. J., Hastie, A. T., Edsall, L. C., Hoffman, R. K., Amrani, Y., Krymskaya, V. P., Kane, S. A., Peters, S. P., Penn, R. B., Spiegel, S., et al. (2001) · The FASEB Journal · doi:10.1096/fj.00-0742fje · Cited by 313
Role of lysophosphatidic acid and its receptors in health and disease: novel therapeutic strategies
Geraldo, L. H. M., Spohr, T. C. L. D. S., Amaral, R. F. D., Fonseca, A. C. C. D., Garcia, C., Mendes, F. D. A., Freitas, C., dosSantos, M. F., & Lima, F. R. S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00367-5 · Cited by 313
Mechanisms of lysophosphatidic acid production
Aoki, J. (2004) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.05.001 · Cited by 305
Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1
Xu, Y., Zhu, K., Hong, G., Wu, W., Baudhuin, L. M., Xiao, Y.-J., & Damron, D. S. (2000) · Nature Cell Biology · doi:10.1038/35010529 · Cited by 289
RetractedOkamoto, H., Takuwa, N., Gonda, K., Okazaki, H., Chang, K., Yatomi, Y., Shigematsu, H., & Takuwa, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27104 · Cited by 282
Hama, K., Aoki, J., Fukaya, M., Kishi, Y., Sakai, T., Suzuki, R., Ohta, H., Yamori, T., Watanabe, M., Chun, J., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313927200 · Cited by 276
Bandoh, K., Aoki, J., Taira, A., Tsujimoto, M., Arai, H., & Inoue, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01827-5 · Cited by 261
Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA6
Yanagida, K., Masago, K., Nakanishi, H., Kihara, Y., Hamano, F., Tajima, Y., Taguchi, R., Shimizu, T., & Ishii, S. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808506200 · Cited by 258
Chun, J., Kihara, Y., Jonnalagadda, D., & Blaho, V. A. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021358 · Cited by 131
“Its complementary DNA sequence enabled deorphanization of homologous receptor genes, which were known by multiple orphan receptor names at the time (47), particularly EDG (20, 48), leading to additional receptors for both LPA (49, 50) and S1P (51, 52).”
BackgroundPlacental expression of lysophosphatidic acid receptors in normal pregnancy and preeclampsia
Fujii, T., Nagamatsu, T., Schust, D. J., Ichikawa, M., Kumasawa, K., Yabe, S., Iriyama, T., Hirota, Y., Osuga, Y., Aoki, J., et al. (2019) · American Journal of Reproductive Immunology · doi:10.1111/aji.13176 · Cited by 19
Metadata
- Authors
- An, S., Bleu, T., Hallmark, O. G., & Goetzl, E. J.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1998-04
- Volume
- 273
- Issue
- 14
- Pages
- 7906-7910
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1977733200
- Cited by
- 528
- References
- 18
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.